Accès ouvert · CC BY

Repurposing of Anti-malarial SynriamTM and testing its efficacy against Egyptian strain of Schistosoma hematobium

Article scientifique 2020 Sciences de la santé Anglais

Résumé

Abstract Background: Trials for discovering an anti-malarial drug, which can compete Schistosomal infection in co-endemic areas, are ongoing. Some preliminary studies were done on Synriam (SYN), anti-malarial drug combination (arterolane maleate and piperaquine phosphate) released from Ranbaxy, to test its anti-schistosomal effect. However, in vitro incubation of SYN with different Schistosoma hematobium stages was not fully assessed. The aim of this study is to determine the anti-schistosomal in vitro effect of SYN on adult and juvenile stages of Schistosoma hematobium- Egyptian strain.Methods: The adult and juvenile worms were incubated with ascending concentrations of SYN and with praziquantel as positive control. Viability, survival, morphological and ultrastructural changes were assessed at different time points.Results: Higher concentrations of 60, 80 µg/ml showed rapid and lethal effects on adult and juvenile stages of both species, with prominent ultrastructural alterations. Concentrations of (10, 20, 40 µg/ml) showed mild to moderate effect on adult schistosomes. However, contrarily to praziquantel, larval immature stages responded significantly and rapidly to low concentration of SYN with 100% death rate.Conclusion: The present findings are consistent with the evaluation of anti-schistosomal therapeutic effect of SYN to be utilized in malaria co-endemic areas.

Citer ce document

Yousof, H.-A. S. A., El-Sayed, S. H., Elfar, E., & Khater, M. M. (2020). Repurposing of Anti-malarial SynriamTM and testing its efficacy against Egyptian strain of Schistosoma hematobium. https://doi.org/10.21203/rs.3.rs-19811/v1

Exporter : BibTeX · RIS (Zotero, Mendeley, EndNote)

Accès au document

Texte intégral archivé sur SPHAERO, en accès ouvert : lisible gratuitement en ligne après connexion. Le document reste aussi disponible à sa source. Se connecter

Voir l'article sur le site de la revue

Licence et provenance

Licence : CC BY

Notice moissonnée depuis OpenAlex le 04/09/2026. Le document reste hébergé par sa source.
Voir le document à la source →

Statistiques

Consultations (hors robots) : 11

Téléchargements (hors robots) : 0

Méthode de comptage